FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
ISUPREL
isoproterenol hydrochloride
LOE Approaching
Sanofi
RECTAL, SUBLINGUAL · TABLET
1948
NDA
30/100
ISUPREL
isoproterenol hydrochloride
LOE Approaching
Bausch + Lomb
INJECTION · INJECTABLE
1956
NDA
30/100
IV PERSANTINE
dipyridamole
LOE Approaching
Boehringer Ingelheim
INJECTION · INJECTABLE
1990
NDA
30/100
IVADANTIN
nitrofurantoin sodium
LOE Approaching
INJECTION · INJECTABLE
1960
NDA
30/100
IVY BLOCK
bentoquatam
LOE Approaching
TOPICAL · LOTION
1996
NDA
30/100
IXEMPRA KIT
ixabepilone
LOE Approaching
R-Pharm US
INTRAVENOUS · INJECTABLE
breast cancer
2007
NDA
30/100
JADELLE
levonorgestrel
LOE Approaching
Medica Corp
IMPLANTATION · IMPLANT
1996
NDA
30/100
JADENU SPRINKLE
deferasirox
Peak
Novartis
ORAL · GRANULE
2017
NDA
30/100
JALYN
dutasteride and tamsulosin hydrochloride
LOE Approaching
Viatris (2)
ORAL · CAPSULE
2010
NDA
30/100
JANIMINE
imipramine hydrochloride
LOE Approaching
Abbott
ORAL · TABLET
1974
NDA
30/100
JASCAYD
nerandomilast
Launch
Boehringer Ingelheim
ORAL · TABLET
2025
NDA
30/100
JENLOGA
clonidine hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
2009
NDA
30/100
JUNIOR STRENGTH ADVIL
ibuprofen
LOE Approaching
GSK
ORAL · TABLET, CHEWABLE
1998
SMNDA
30/100
JUNIOR STRENGTH ADVIL
ibuprofen
LOE Approaching
GSK
ORAL · TABLET
1996
SMNDA
30/100
JUNIOR STRENGTH MOTRIN
ibuprofen
LOE Approaching
ORAL · TABLET, CHEWABLE
1996
SMNDA
30/100
JUNIOR STRENGTH MOTRIN
ibuprofen
LOE Approaching
ORAL · TABLET
1996
SMNDA
30/100
K-TAB
potassium chloride
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
1980
NDA
30/100
KADIAN
morphine sulfate
LOE Approaching
AbbVie
ORAL · CAPSULE, EXTENDED RELEASE
1996
NDA
30/100
KAFOCIN
cephaloglycin
LOE Approaching
Eli Lilly and Company
ORAL · CAPSULE
1970
NDA
30/100
KALETRA
lopinavir and ritonavir
LOE Approaching
AbbVie
ORAL · TABLET
2005
SMNDA
30/100
KALETRA
lopinavir; ritonavir
LOE Approaching
AbbVie
ORAL · CAPSULE
2000
SMNDA
30/100
KALETRA
lopinavir and ritonavir
LOE Approaching
AbbVie
ORAL · SOLUTION
2000
SMNDA
30/100
KAPVAY
clonidine hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
2009
NDA
30/100
KAYEXALATE
sodium polystyrene sulfonate
LOE Approaching
ORAL, RECTAL · POWDER
1958
NDA
30/100
← PreviousPage 91 of 277Next →